Professor Parry Guilford

Research Professor
  • Biochemistry Department
  • School of Biomedical Sciences
  • University of Otago
  • P.O. Box 56
  • 710 Cumberland St
  • Dunedin 9054 , New Zealand
  • Tel.: 64 3 479-7673
  • Fax: 64 3 479-7866

Professor Parry Guilford is a Principal Investigator in the Cancer Genetics Laboratory, University of Otago, Dunedin, New Zealand, and the Research Director of Pacific Edge Biotechnology Ltd. He completed his MSc at Otago in 1983, and his PhD at Cambridge University in 1989.  His research interests include the genetics of inherited cancers, in particular gastric cancer, and the application of gene expression analysis to the diagnosis and management of cancer.


  • Parry Guilford
  • 2016, Elected as Fellow of the Royal Society of New Zealand
  • Parry Guilford
  • 2016, BMS Senior Researcher Award
  • Chris Harris
  • 2014, Otago Medical School Research Society's Student Science Writing Prize, 1st place
  • Chris's entry was entitled "Unlocking Prostate Cancer".
  • Professor Parry Guilford
  • 2014, Sir Charles Hercus Medal for excellence in biomedical and health sciences
  • For the discovery of the gene mutation that can lead to hereditary stomach cancer in families.
  • Bryony Telford
  • 2013, Otago School of Medical Sciences Postgraduate Symposium Speaking Award, 2nd place
  • Prof Parry Guilford
  • 2013, HRC Beaven Medal for Translational Research
  • Parry Guilford
  • 2013, OSMS Commercialisation Award
  • "translation of technological innovation to commercial reality"
  • Associate Professor Parry Guilford
  • 2009, James Cook Fellowship

Selected Publications

L Kavalieris, P O'Sullivan, C Frampton, P Guilford, D Darling, E Jacobson, J Suttie, J D Raman, S F Shariat, and Y Lotan., Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study., J Urol 2016., Link »

Andrew Single, Henry Beetham, Bryony J Telford, Parry Guilford, and Augustine Chen., A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation., J Biomol Screen 2015, Link »

Ingrid P Vogelaar, Rachel S van der Post, Fatima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems, Linda Bardram, Patrick R Benusiglio, Tanya M Bisseling, Vanessa Blair, Eveline Bleiker, Alex Boussioutas, Annemieke Cats, Daniel Coit, Lynn DeGregorio, Joana Figueiredo, James M Ford, Esther Heijkoop, Rosella Hermens, Bostjan Humar, Pardeep Kaurah, Gisella Keller, Jennifer Lai, Marjolijn J L Ligtenberg, Maria O'Donovan, Carla Oliveira, Hugo Pinheiro, Krish Ragunath, Esther Rasenberg, Susan Richardson, Franco Roviello, Hans Schackert, Raquel Seruca, Amy Taylor, Anouk Ter Huurne, Marc Tischkowitz, Sheena Tjon A Joe, Benjamin van Dijck, Nicole C T van Grieken, Richard van Hillegersberg, Johanna W van Sandick, Rianne Vehof, J Han Van Krieken, and Rebecca C Fitzgerald., Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers., Journal of medical genetics 2015, Link »

Bryony J Telford, Augustine Chen, Henry Beetham, James Frick, Tom P Brew, Cathryn M Gould, Andrew Single, Tanis Godwin, Kaylene J Simpson, and Parry Guilford., Synthetic lethal screens identify vulnerabilities in GPCR signalling and cytoskeletal organization in E-cadherin-deficient cells., Molecular Cancer Therapeutics 2015., Link »

Samantha Hansford, Pardeep Kaurah, Hector Li-Chang, Michelle Woo, Janine Senz, Hugo Pinheiro, Kasmintan A Schrader, David F Schaeffer, Karey Shumansky, George Zogopoulos, Teresa Almeida Santos, Isabel Claro, Joana Carvalho, Cydney Nielsen, Sarah Padilla, Amy Lum, Aline Talhouk, Katie Baker-Lange, Sue Richardson, Ivy Lewis, Noralane M Lindor, Erin Pennell, Andree MacMillan, Bridget Fernandez, Gisella Keller, Henry Lynch, Sohrab P Shah, Parry Guilford, Steven Gallinger, Giovanni Corso, Franco Roviello, Carlos Caldas, Carla Oliveira, Paul D P Pharoah, and David G Huntsman., Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond., JAMA Oncol 2015 vol. 1 (1) pp. 23-32, Link »

Augustine Chen, Henry Beetham, Michael A Black, Rashmi Priya, Bryony J Telford, Joanne Guest, George A R Wiggins, Tanis D Godwin, Alpha S Yap, and Parry J Guilford, E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition., BMC cancer 2014 vol. 14 p. 552, Link »

Jon Cornwall, Tania Slatter, Parry Guilford, Cristin G. Print, Mark Henaghan, and Richman Wee, Culture, law, ethics, and social implications: Is society ready for advanced genomic medicine?, The Australasian medical journal 2014 vol. 7 (4) pp. 200-202, Link »

J S B Willson, T D Godwin, G A R Wiggins, P J Guilford, and J L McCall, Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation, Journal of Hepatology 2013 vol. 59 (4) pp. 904-907, Link »

P O'Sullivan, K Sharples, M Dalphin, P. Davidson, P Gilling, L Cambridge, J Harvey, T Toro, N Giles, C Luxmanan, C F Alves, H-S Yoon, V Hinder, J Masters, A Kennedy-Smith, T Beaven, and P J Guilford, A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria, Journal of Urology 2012 vol. 188 (3) pp. 741-747, Link »